Xiaowei Liu | OMICS International

Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Xiaowei Liu

  The Biodesign Institute
Center for Infectious Diseases and Vaccinology 
Arizona State University



Dr. Xiaowei Liu received her Ph.D. in Biochemistry from Arizona State University in 2012. During her Ph.D. studies, she focused on DNA nanotechnology and explored the biological applications of DNA nanostructures, with an emphasis on the immunological aspect such as vaccine construction and cell-cell interactions. As a postdoctoral research associate at the Biodesign Institute, Arizona State University, her current research involves rational design and optimization of nicotine vaccine, cancer vaccines, mechanism of DNA nano-vaccines and therapeutic nanoparticles. She is an active reviewer for several reputed journals on immunology and biochemistry.

Research Interest


Vaccines,Immunotherapy, DNA nanotechnology, Drug delivery, Therapeutic nanoparticles 


Global Speakers in the subject

Global Experts in the subject